NOAC Use Not Tied to ICH in Stroke Patients Treated With Alteplase – Consumer Health News

FRIDAY, Feb. 25, 2022 (HealthDay News) — For patients with acute ischemic stroke receiving alteplase, use of non-vitamin K antagonist oral anticoagulants (NOACs) in the previous seven days is not associated with an increased risk for intracranial hemorrhage compared with not using anticoagulants, according to a study published in the Feb. 10 issue of the Journal of the American Medical…

Continue Reading

News Source:

Leave a comment

Your email address will not be published.